Rituximab-ABVD
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rituximab-ABVD, covering 2015-07-03 to 2015-07-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma [Phase 2]